About the job
Innovators Needed
When was the last time you accomplished something extraordinary? If that question excites you, keep reading.
Since our inception in 2015, we have adopted an innovative approach akin to a “moneyball for biotech,” pooling projects and promising early-stage research from academia under a single financial paradigm to mitigate risk and catalyze innovation. This model empowers scientific inquiry and small expert teams to drive progress. Our goal is to bridge the gap to groundbreaking advancements in rare diseases and swiftly develop transformative medicines for patients facing unmet medical needs.
At BridgeBio, we redefine boundaries, encourage curiosity, and empower individuals to tackle challenges. If you're someone who challenges the status quo, join us in collaborating with some of the brightest minds in the industry. Together, we will ask, “why not?” and help reshape the future of biopharmaceuticals. We value innovation and the ethical application of AI to enhance clarity, speed, and quality of our work.
About BridgeBio Pharma, Inc.
BridgeBio is a pioneering biopharmaceutical company committed to discovering, developing, and delivering transformative medicines for patients with genetic diseases and genetically defined cancers. Since our founding in 2015, we have established a robust portfolio of over 20 drug development programs, spanning from early discovery to late-stage clinical trials across diverse therapeutic areas, including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have successfully gained regulatory approval for three therapies and continue to advance promising scientific research from academia into effective treatments for patients globally.
